Enhance Pathway Analysis in Disease-Relevant Cell Types Using ViaFect™ Transfection Reagent

10 Sept 2014

This poster demonstrates that by using ViaFect™ for transient delivery of various reporter constructs, oncogenic and pro-inflammatory signaling pathways can be interrogated in hematopoietic cell lines and iPS-derived cells.

ViaFect™ Transfection Reagent

Promega Corp.

ViaFect™ Transfection Reagent allows high-efficiency transfection of a wide range of cell types, including iPS Cells, without compromising cell viability.   ViaFect™ Transfection Reagent enables the design of biologically relevant assays in workhorse adherent cell models, suspension cells important for studying cell signaling, and even differentiated cell lines derived from stem cells. ViaFect™ Transfection Reagent offers an easy-to-use protocol that provides superior performance with minimal optimization, allowing you to design the right assay in the right cells to model the biology you are studying. ViaFect Transfection Reagent requires minimal optimization with a simple three-step protocol. It does not require removal of serum, removal of culture medium or washing after introduction of the reagent/DNA complex. ViaFect Transfection Reagent contains no animal-derived components.  

(4)

Links

Tags

Enhance Pathway Analysis in Disease-Relevant Cell Types Using ViaFect™ Transfection Reagent